Navigation Links
Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years

ROCHESTER, N.Y., May 02, 2007 /PRNewswire/ -- A new Harris Poll suggests that the flu vaccine used before last winter may have been less effective than the vaccines used in some previous years. The adults who had flu shots before last winter were only 24 percent less likely to get the flu than those who were not vaccinated. The differences were larger in two previous Harris Polls on the same topic.(1) In the winters of 2003/2004 and 2004/2005 adults who were vaccinated were 33 percent and 43 percent less likely to have gotten the flu than those who were not.

These are some of the results of a nationwide Harris Poll of 2,563 U.S. adults surveyed online by Harris Interactive(R) between April 10 and 16, 2007.

All of these results should be treated with some caution. People's memories of whether they had flu shots may not be completely accurate. This is not a double-blind clinical trial, which is the gold standard for measuring the effectiveness of drugs. Furthermore, experts on the flu say that it is easy to confuse it with other infections, so some people who believe that they had the flu may not actually have had it. However, a large 71 percent majority of those who received flu shots and who believe they had the flu say they are certain they had it; but only just over a third (39%) visited a doctor who diagnosed the flu. The techniques used in this year's survey are the same as those used in previous years.

    The main findings of this survey include:


    - Approximately one-third (35%) of all adults claim to have had a flu shot

      before the winter of 2006/2007. This includes a much higher proportion

      (73%) of people aged 65 and over, who are regarded as more seriously at

      risk from the flu if they catch it;


    - Fifteen percent of all adults believe they had the flu, somewhat below

      the 18 percent and 21 percent who believe they had the flu in the

      winters of 2003/2004 (18%) and 2004/2005 (21%);


    - 
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Post Your Comments:
(Date:10/22/2014)... , Oct. 22, 2014  Medical ... laboratory which specializes in high complexity, state-of-the-art, ... is now offering new Cystic Fibrosis Testing ... generation DNA sequencing platforms. Cystic ... inherited multisystem disorder that affects the respiratory, ...
(Date:10/22/2014)... FAIRFIELD, N.J. , Oct. 22, 2014 /PRNewswire/ ... a major transformation in the pain market, according ... Pain Insights, Inc., a firm providing market research ... management. Photo - http://photos.prnewswire.com/prnh/20141021/153440 ... a scheduling change for hydrocodone combination products from ...
(Date:10/22/2014)... October 22, 2014 Investor-Edge has ... (NASDAQ: FOLD ), Progenics Pharmaceuticals Inc. (NASDAQ: ... THLD ), Idera Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... 2014, the NASDAQ Composite ended at 4,419.48, up 2.40%, ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C. Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5
... and VANCOUVER, April 26, 2007,/PRNewswire-FirstCall/ - Angiotech ... medical device company, announced that,the two-year data ... Wrap(TM) Paclitaxel-Eluting Mesh ("Vascular Wrap(TM)"),will be presented ... The,two-year study examined the safety and efficacy ...
... 26, 2007 - A new study published ... ("A National Survey of,Physician-Industry Relationships") on the ... the need for,profession-wide and public policy reforms ... that the existing,voluntary PhRMA (Pharmaceutical Research and ...
Cached Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Ties Between Physicians and Drug Companies Still Too Strong: the,Prescription Project Offers Solutions to Prevent Conflicts of,Interest 2
(Date:10/25/2014)... TASC (Total Administrative Services Corporation), ... account management services, announces the release of four ... taxes, reduce administrative workload, and lessen liability. ... the efficient handling of complex, time-sensitive, and labor-consuming ... meets their goals and objectives. The four Suites ...
(Date:10/25/2014)... 2014 QueenBeeTickets.com has a variety of ... at affordable prices. Bob Seger & The Silver Bullet ... Nationwide Arena are going on sale October 25 and ... to browse the selection of tickets for Bob ... The famous singer is touring North America beginning next ...
(Date:10/25/2014)... October 25, 2014 Mesothelioma researchers are ... to receive pemetrexed (Alimta), after his combination drug therapy ... full story , just posted on the Surviving Mesothelioma ... Tokushukai Medical Center in Japan suggests that “maintenance therapy” ... patients who cannot tolerate higher doses of cisplatin. ...
(Date:10/25/2014)... Reinberg HealthDay Reporter FRIDAY, ... common cold sores -- herpes simplex -- might increase the ... In fact, being a carrier of certain antibodies to ... researchers found. "The identification of a treatable cause ... breakthrough," said lead researcher Dr. Hugo Lovheim, an associate professor ...
(Date:10/25/2014)... News) -- A large influx of international aid is ... tens of thousands of deaths from the widening Ebola ... Using a specially designed mathematical model, the researchers ... just one densely populated county of hard-hit Liberia -- ... The researchers said that if international aid isn,t ...
Breaking Medicine News(10 mins):Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2
... and television that anger causes// the cardiac arrest of ... Yale University researchers have found out that sudden strong ... in the heart to twitch. This may be especially ... although seemingly healthy people my also be affected. ...
... Surrey, UK, had developed a new// drug that will boost ... is made of a compound called CX717, and it is ... This drug had showed effectiveness in increasing memeory, alertness, increasing ... who sleep less. ,The drug was given to ...
... had successfully created a new breed of mice that can ... for themselves.//, ,The reactive oxygen of the free radicals ... to poor health and even death. The new research may ... radical theory of ageing. ,The new mice created ...
... may lead to babies born with deformed prostate glands.//, ... out that prostate deformities can happen if the pregnant ... The pills contain ostrogen like chemiclasthat are alos present ... can cause prostate cancer or bladder diseases later in ...
... study that looked into the smoking habit of 6654 people ... that giving up smoking do causes weight gain, but the ... population under study was measured for effect of giving up ... when the age group was 20 to 44yrs, and was ...
... levels of blood marker for inflammation that can //lead to ... say that it may be good for the health of ... man will have a close family, a good group of ... the workplace, or the neighbors, or a religious organization. ...
Cached Medicine News:
... Worlds First Solid-State Three-Color Photocoagulator.,Retinal physicians ... purchase over 3,000 Lumenis multi-color photocoagulators.,For ... practice, the Novus Varia integrates green, ... a single, compact system that supports ...
... rings, Type 14, 14A and 14C have been ... diameters to accommodate the variations in the size ... capsular tension rings are designed to stabilize the ... a large panel of U.S. ophthalmologists. For ...
Hannum rongeur/grasper with teth in jaws and non-locking design....
Heavy Duty Locking Pliers...
Medicine Products: